603520 司太立
已收盘 10-13 15:00:00
资讯
新帖
简况
司太立（603520）9月30日主力资金净买入848.00万元
证券之星 · 09-30
司太立（603520）9月30日主力资金净买入848.00万元
每周股票复盘：XD司太立（603520）司太立每股派现0.05元含税
证券之星 · 09-13
每周股票复盘：XD司太立（603520）司太立每股派现0.05元含税
股市必读：司太立新发布《司太立2026年半年度权益分派实施公告》
证券之星 · 09-07
股市必读：司太立新发布《司太立2026年半年度权益分派实施公告》
每周股票复盘：司太立（603520）2026上半年净利增37.05%
证券之星 · 09-06
每周股票复盘：司太立（603520）2026上半年净利增37.05%
司太立（603520）2026年中报简析：营收净利润同比双双增长，盈利能力上升
证券之星 · 09-01
司太立（603520）2026年中报简析：营收净利润同比双双增长，盈利能力上升
司太立(603520)6月30日股东户数5.22万户，较上期增加4.66%
证券之星 · 08-30
司太立(603520)6月30日股东户数5.22万户，较上期增加4.66%
司太立最新公告：2026年半年度净利润同比增长37.05%
证券之星 · 08-30
司太立最新公告：2026年半年度净利润同比增长37.05%
股市必读：司太立新发布《司太立关于实际控制人减持股份结果暨一致行动人之间内部转让股份完成公告》
证券之星 · 08-17
股市必读：司太立新发布《司太立关于实际控制人减持股份结果暨一致行动人之间内部转让股份完成公告》
每周股票复盘：司太立（603520）实控人减持1.00%并转让1.57%股份
证券之星 · 08-16
每周股票复盘：司太立（603520）实控人减持1.00%并转让1.57%股份
司太立（603520）披露实际控制人减持股份结果暨一致行动人之间内部转让股份完成公告，8月13日股价下跌0.55%
证券之星 · 08-13
司太立（603520）披露实际控制人减持股份结果暨一致行动人之间内部转让股份完成公告，8月13日股价下跌0.55%
8月12日司太立现1笔折价10.6%的大宗交易 合计成交5575.26万元
证券之星 · 08-12
8月12日司太立现1笔折价10.6%的大宗交易 合计成交5575.26万元
每周股票复盘：司太立（603520）董事减持58.61万股
证券之星 · 08-09
每周股票复盘：司太立（603520）董事减持58.61万股
每周股票复盘：司太立（603520）董事减持50万股
证券之星 · 07-26
每周股票复盘：司太立（603520）董事减持50万股
7月24日司太立跌6.10%，银河医药混合A基金重仓该股
证券之星 · 07-24
7月24日司太立跌6.10%，银河医药混合A基金重仓该股
司太立：7月23日董事胡锦生减持股份合计50万股
证券之星 · 07-23
司太立：7月23日董事胡锦生减持股份合计50万股
7月20日司太立跌5.41%，银河医药混合A基金重仓该股
证券之星 · 07-20
7月20日司太立跌5.41%，银河医药混合A基金重仓该股
每周股票复盘：司太立（603520）胡锦生减持181.8万股并解除1800万股质押
证券之星 · 07-19
每周股票复盘：司太立（603520）胡锦生减持181.8万股并解除1800万股质押
司太立（603520）披露控股股东股份解除质押公告，7月16日股价下跌0.31%
证券之星 · 07-16
司太立（603520）披露控股股东股份解除质押公告，7月16日股价下跌0.31%
司太立：7月13日至7月14日董事胡锦生减持股份合计181.8万股
证券之星 · 07-16
司太立：7月13日至7月14日董事胡锦生减持股份合计181.8万股
司太立（603520）披露持股5%以上股东权益变动触及1%刻度，7月13日股价下跌2.8%
证券之星 · 07-13
司太立（603520）披露持股5%以上股东权益变动触及1%刻度，7月13日股价下跌2.8%
暂无数据
公司概况
公司名称：
浙江司太立制药股份有限公司
所属行业：
医药制造业
上市日期：
2016-03-09
主营业务：
浙江司太立制药股份有限公司的主营业务是医药特色原料药研发、生产与销售。公司的主要产品是碘海醇注射液、碘帕醇注射液、碘克沙醇注射液、碘美普尔注射液、碘佛醇注射液、碘普罗胺注射液、钆贝葡胺注射液、钆喷酸葡胺注射液、造影剂类原料药及中间体、喹诺酮类原料药及中间体、CMO/CDMO类原料药及中间体。
发行价格：
12.15
{"stockData":{"symbol":"603520","market":"SH","secType":"STK","nameCN":"司太立","latestPrice":8.42,"timestamp":1791874800000,"preClose":8.53,"halted":0,"volume":7678143,"delay":0,"changeRate":-0.0129,"floatShares":438000000,"shares":438000000,"eps":0.048,"marketStatus":"已收盘","change":-0.11,"latestTime":"10-13 15:00:00","open":8.45,"high":8.5,"low":8.24,"amount":64223300,"amplitude":0.0305,"askPrice":8.42,"askSize":316,"bidPrice":8.41,"bidSize":894,"shortable":0,"etf":0,"ttmEps":0.048,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791941400000},"marketStatusCode":5,"adr":0,"adjPreClose":8.53,"symbolType":"stock","openAndCloseTimeList":[[1791855000000,1791862200000],[1791867600000,1791874800000]],"highLimit":9.38,"lowLimit":7.68,"ibTradeSell":true,"ibTradeBuySell":false,"totalEquity":438409881,"isCdr":false,"pbRate":1.49,"roa":"--","peRate":175.416667,"roe":"1.55%","epsLYR":0.02,"committee":0.420905,"marketValue":3691000000,"turnoverRate":0.0175,"status":1,"floatMarketCap":3691000000},"requestUrl":"/m/hq/s/603520/tweets","defaultTab":"tweets","newsList":[{"id":"2671127625","title":"司太立（603520）9月30日主力资金净买入848.00万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671127625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671127625?lang=zh_cn&edition=full","pubTime":"2026-09-30 15:22","pubTimestamp":1790752929,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月30日收盘，司太立报收于8.75元，上涨4.29%，换手率2.81%，成交量12.33万手，成交额1.07亿元。9月30日的资金流向数据方面，主力资金净流入848.0万元，占总成交额7.96%，游资资金净流出224.73万元，占总成交额2.11%，散户资金净流出623.27万元，占总成交额5.85%。司太立主营业务：专业从事医药特色原料药研发、生产与销售的高新技术企业。该股最近90天内共有1家机构给出评级，买入评级1家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000018854.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667500615","title":"每周股票复盘：XD司太立（603520）司太立每股派现0.05元含税","url":"https://stock-news.laohu8.com/highlight/detail?id=2667500615","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667500615?lang=zh_cn&edition=full","pubTime":"2026-09-13 03:26","pubTimestamp":1789241173,"startTime":"0","endTime":"0","summary":"截至2026年9月11日收盘，XD司太立报收于8.25元，较上周的8.78元下跌6.04%。本周，XD司太立9月8日盘中最高价报8.92元。XD司太立当前最新总市值36.17亿元，在化学制药板块市值排名115/149，在两市A股市值排名3902/5218。本周关注点公司公告汇总：司太立每股派发现金红利0.05元（含税），股权登记日为2026年9月10日。本次利润分配以公司总股本438,409,881股为基数，共计派发现金红利21,920,494.05元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091300001061.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665678703","title":"股市必读：司太立新发布《司太立2026年半年度权益分派实施公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2665678703","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665678703?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:37","pubTimestamp":1788716228,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，司太立报收于8.78元，上涨0.0%，换手率1.17%，成交量5.13万手，成交额4542.24万元。公司公告汇总：司太立将于2026年9月11日实施2026年半年度权益分派，每股派发现金红利0.05元（含税），共计派发21,920,494.05元。个人股东持股期限不同，税负有所差异，持股1个月内税负20%，1个月至1年税负10%，超过1年免税。QFII及沪股通投资者按10%税率代扣代缴所得税。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000818.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665366685","title":"每周股票复盘：司太立（603520）2026上半年净利增37.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366685","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665366685?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:32","pubTimestamp":1788636731,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，司太立报收于8.78元，较上周的9.05元下跌2.98%。本周关注点来自业绩披露要点：司太立2026年上半年归母净利润同比增长37.05%。公司公告汇总浙江司太立制药股份有限公司2026年半年度报告摘要显示，截至报告期末，公司总资产为5,997,416,052.13元，较上年度末减少2.56%；归属于上市公司股东的净资产为2,477,329,761.57元，较上年度末减少3.15%。浙江司太立制药股份有限公司发布2026年“提质增效重回报”行动方案的半年度评估报告，披露2026年上半年经营进展。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600001195.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664885462","title":"司太立（603520）2026年中报简析：营收净利润同比双双增长，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2664885462","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664885462?lang=zh_cn&edition=full","pubTime":"2026-09-01 06:07","pubTimestamp":1788214060,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期司太立发布2026年中报。截至本报告期末，公司营业总收入14.14亿元，同比上升1.18%，归母净利润3992.9万元，同比上升37.05%。按单季度数据看，第二季度营业总收入7.03亿元，同比下降1.25%，第二季度归母净利润1897.54万元，同比上升28.29%。本报告期司太立盈利能力上升，毛利率同比增幅0.37%，净利率同比增幅33.94%。本文数据来源于司太立2026年中报，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100004737.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663049172","title":"司太立(603520)6月30日股东户数5.22万户，较上期增加4.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663049172","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663049172?lang=zh_cn&edition=full","pubTime":"2026-08-30 17:07","pubTimestamp":1788080821,"startTime":"0","endTime":"0","summary":"证券之星消息，近日司太立披露，截至2026年6月30日公司股东户数为5.22万户，较3月31日增加2324.0户，增幅为4.66%。在化学制药行业个股中，司太立股东户数高于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年3月31日至2026年6月30日，司太立区间涨幅为5.13%，在此期间股东户数增加2324.0户，增幅为4.66%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000011017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663104954","title":"司太立最新公告：2026年半年度净利润同比增长37.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663104954","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663104954?lang=zh_cn&edition=full","pubTime":"2026-08-30 16:30","pubTimestamp":1788078626,"startTime":"0","endTime":"0","summary":"司太立(603520.SH)发布2026年半年度报告，实现营业收入14.14亿元，同比增长1.18%；归属于上市公司股东的净利润3992.9万元，同比增长37.05%。公司拟向全体股东每10股派发现金红利0.5元(含税)。注：公司Q2净利润0.19亿，Q1净利润0.21亿，据此计算，Q2净利润环比下降9%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000009018.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660170180","title":"股市必读：司太立新发布《司太立关于实际控制人减持股份结果暨一致行动人之间内部转让股份完成公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2660170180","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660170180?lang=zh_cn&edition=full","pubTime":"2026-08-17 02:13","pubTimestamp":1786903990,"startTime":"0","endTime":"0","summary":"公司公告汇总：实际控制人胡锦生完成减持计划，集中竞价减持1.00%股份，同时向一致行动人孙女内部转让1.57%股份，合计持股比例下降1.00个百分点。本次减持计划已实施完毕，减持后胡锦生持股比例由10.2808%降至7.7108%，其与一致行动人合计持股比例由22.3366%降至21.3366%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700000816.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659117500","title":"每周股票复盘：司太立（603520）实控人减持1.00%并转让1.57%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2659117500","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659117500?lang=zh_cn&edition=full","pubTime":"2026-08-16 02:32","pubTimestamp":1786818733,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，司太立报收于9.0元，较上周的9.06元下跌0.66%。来自公司公告汇总：实控人胡锦生集中竞价减持1.00%股份，大宗交易转让1.57%予孙女胡思慧，合计持股比例降至21.3366%。股本股东变化2026年8月12日，公司董事胡锦生减持688.3万股，占公司总股本1.57%，变动原因为一致行动人之间内部持股结构调整，受让方为其孙女胡思慧。本次减持计划已实施完毕，胡锦生持股比例由10.2808%降至7.7108%，其与一致行动人合计持股比例由22.3366%降至21.3366%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000621.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659316394","title":"司太立（603520）披露实际控制人减持股份结果暨一致行动人之间内部转让股份完成公告，8月13日股价下跌0.55%","url":"https://stock-news.laohu8.com/highlight/detail?id=2659316394","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659316394?lang=zh_cn&edition=full","pubTime":"2026-08-13 22:36","pubTimestamp":1786631778,"startTime":"0","endTime":"0","summary":"截至2026年8月13日收盘，司太立报收于9.01元，较前一交易日下跌0.55%，最新总市值为39.5亿元。近日，司太立发布《关于实际控制人减持股份结果暨一致行动人之间内部转让股份完成公告》。本次减持计划已实施完毕，减持后胡锦生持股比例由10.2808%降至7.7108%，其与一致行动人合计持股比例由22.3366%降至21.3366%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300039960.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658973065","title":"8月12日司太立现1笔折价10.6%的大宗交易 合计成交5575.26万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2658973065","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658973065?lang=zh_cn&edition=full","pubTime":"2026-08-12 17:33","pubTimestamp":1786527229,"startTime":"0","endTime":"0","summary":"证券之星消息，8月12日司太立发生大宗交易，交易数据如下：大宗交易成交价格8.1元，相对当日收盘价折价10.6%，成交688.3万股，成交金额5575.26万元，买方营业部为中国银河证券股份有限公司重庆江津证券营业部，卖方营业部为中国银河证券股份有限公司重庆江南大道证券营业部。近三个月该股共发生1笔大宗交易，合计成交6.88万手，折价成交1笔。截至2026年8月12日收盘，司太立报收于9.06元，上涨0.67%，换手率1.44%，成交量6.33万手，成交额5737.99万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200030074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658867517","title":"每周股票复盘：司太立（603520）董事减持58.61万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658867517","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658867517?lang=zh_cn&edition=full","pubTime":"2026-08-09 03:02","pubTimestamp":1786215739,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，司太立报收于9.06元，较上周的8.66元上涨4.62%。本周，司太立8月7日盘中最高价报9.06元。司太立当前最新总市值39.72亿元，在化学制药板块市值排名112/149，在两市A股市值排名3666/5205。股本股东变化高管增减持2026年8月6日，司太立董事胡锦生减持公司股份58.61万股，占公司总股本的0.1337%。变动期间公司股价下跌0.9%，当日收盘价为8.84元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000999.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654205228","title":"每周股票复盘：司太立（603520）董事减持50万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2654205228","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654205228?lang=zh_cn&edition=full","pubTime":"2026-07-26 01:44","pubTimestamp":1785001454,"startTime":"0","endTime":"0","summary":"截至2026年7月24日收盘，司太立报收于8.0元，较上周的9.05元下跌11.6%。本周，司太立7月20日盘中最高价报9.11元。司太立当前最新总市值35.07亿元，在化学制药板块市值排名111/149，在两市A股市值排名3674/5200。本周关注点股本股东变化：公司董事胡锦生减持50.0万股，占总股本0.114%交易信息汇总：变动期间公司股价上涨0.47%，7月23日收盘报8.52元股本股东变化高管增减持2026年7月23日，司太立董事胡锦生减持公司股份50.0万股，占公司总股本0.114%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072600000346.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653707018","title":"7月24日司太立跌6.10%，银河医药混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653707018","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653707018?lang=zh_cn&edition=full","pubTime":"2026-07-24 16:38","pubTimestamp":1784882303,"startTime":"0","endTime":"0","summary":"证券之星消息，7月24日司太立跌6.10%创60日新低，收盘报8.0元，换手率2.79%，成交量12.24万手，成交额1.0亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为银河基金的银河医药混合A。方伟在任的基金产品包括:银河康乐股票A，管理时间为2021年5月10日至今，期间收益率为-32.32%；银河医药混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072400028593.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","159938","BK1161","BK1515","09939","BK1574","603520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653472747","title":"司太立：7月23日董事胡锦生减持股份合计50万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2653472747","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653472747?lang=zh_cn&edition=full","pubTime":"2026-07-23 20:01","pubTimestamp":1784808089,"startTime":"0","endTime":"0","summary":"证券之星消息，根据7月23日市场公开信息、上市公司公告及交易所披露数据整理，司太立（603520）最新董监高及相关人员股份变动情况：2026年7月23日公司董事胡锦生共减持公司股份50.0万股，占公司总股本为0.114%。变动期间公司股价上涨0.47%，7月23日当日收盘报8.52元。司太立近半年内的董监高及核心技术人员增减持详情如下：司太立的高管列表及最新持股情况如下：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家；过去90天内机构目标均价为13.73。本文数据来源于上海证券交易所信息披露、司太立公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300043645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652295298","title":"7月20日司太立跌5.41%，银河医药混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2652295298","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652295298?lang=zh_cn&edition=full","pubTime":"2026-07-20 16:20","pubTimestamp":1784535617,"startTime":"0","endTime":"0","summary":"证券之星消息，7月20日司太立跌5.41%创60日新低，收盘报8.56元，换手率4.0%，成交量17.54万手，成交额1.55亿元。根据2026基金Q1季报公募基金重仓股数据，重仓该股的公募基金共5家，其中持有数量最多的公募基金为银河基金的银河医药混合A。方伟在任的基金产品包括:银河康乐股票A，管理时间为2021年5月10日至今，期间收益率为-32.35%；银河医药混合A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072000024282.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK0239","159938","BK1574","09939","BK1161","603520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652230373","title":"每周股票复盘：司太立（603520）胡锦生减持181.8万股并解除1800万股质押","url":"https://stock-news.laohu8.com/highlight/detail?id=2652230373","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652230373?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:20","pubTimestamp":1784398820,"startTime":"0","endTime":"0","summary":"股本股东变化高管增减持2026年7月13日至14日，公司董事胡锦生减持181.8万股，占公司总股本0.4147%。2026年7月10日，胡锦生减持108.0万股，占公司总股本0.2463%。本次变动后，胡锦生及其一致行动人合计持股比例由22.25%降至22.00%。司太立发布控股股东股份解除质押公告。胡锦生于2026年7月10日和7月15日分别解除质押500万股和1300万股，合计解除1800万股，占公司总股本4.11%，占其持股比例43.09%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000657.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651428166","title":"司太立（603520）披露控股股东股份解除质押公告，7月16日股价下跌0.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651428166","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651428166?lang=zh_cn&edition=full","pubTime":"2026-07-16 22:42","pubTimestamp":1784212934,"startTime":"0","endTime":"0","summary":"截至2026年7月16日收盘，司太立报收于9.73元，较前一交易日下跌0.31%，最新总市值为42.66亿元。该股当日开盘9.66元，最高9.8元，最低9.39元，成交额达1.59亿元，换手率为3.77%。近日，司太立发布关于控股股东股份解除质押的公告。本次解除质押后，胡锦生先生剩余被质押股份为16,900,000股，占其所持股份比例40.46%。截至公告日，控股股东胡锦生、胡健及其一致行动人合计持有公司股份94,628,256股，占总股本21.58%；累计质押股份24,650,000股，占其持股比例26.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600040480.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651441995","title":"司太立：7月13日至7月14日董事胡锦生减持股份合计181.8万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2651441995","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651441995?lang=zh_cn&edition=full","pubTime":"2026-07-16 20:01","pubTimestamp":1784203293,"startTime":"0","endTime":"0","summary":"证券之星消息，根据7月16日市场公开信息、上市公司公告及交易所披露数据整理，司太立（603520）最新董监高及相关人员股份变动情况：2026年7月13日至2026年7月14日公司董事胡锦生共减持公司股份181.8万股，占公司总股本为0.4147%。变动期间公司股价下跌4.56%，7月14日当日收盘报9.2元。司太立近半年内的董监高及核心技术人员增减持详情如下：司太立的高管列表及最新持股情况如下：该股最近90天内共有4家机构给出评级，买入评级3家，增持评级1家；过去90天内机构目标均价为13.73。本文数据来源于上海证券交易所信息披露、司太立公告，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600035939.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603520"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651459110","title":"司太立（603520）披露持股5%以上股东权益变动触及1%刻度，7月13日股价下跌2.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2651459110","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651459110?lang=zh_cn&edition=full","pubTime":"2026-07-13 22:44","pubTimestamp":1783953850,"startTime":"0","endTime":"0","summary":"截至2026年7月13日收盘，司太立报收于9.37元，较前一交易日下跌2.8%，最新总市值为41.08亿元。近日，公司披露《持股5%以上的股东权益变动触及1%刻度》公告。公告显示，司太立实际控制人胡锦生于2026年7月10日通过集中竞价方式减持公司股份1,080,000股，持股比例由10.19%降至9.94%。本次变动后，胡锦生及其一致行动人合计持股比例由22.25%降至22.00%。本次权益变动为履行此前披露的减持计划，不触及要约收购，未违反承诺，不影响公司控制权及持续经营。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071300040797.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603520","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791918192934,"stockEarnings":[{"period":"1week","weight":-0.0377},{"period":"1month","weight":0.0206},{"period":"3month","weight":-0.1322},{"period":"6month","weight":-0.2174},{"period":"1year","weight":-0.211},{"period":"ytd","weight":-0.0759}],"compareEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.0224},{"period":"3month","weight":-0.0391},{"period":"6month","weight":-0.0628},{"period":"1year","weight":-0.0228},{"period":"ytd","weight":-0.0423}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"浙江司太立制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"52159人(较上一季度增加4.66%)","perCapita":"8405股","listingDate":"2016-03-09","address":"浙江省台州市仙居县现代工业集聚区司太立大道1号","registeredCapital":"43840万元","survey":" 浙江司太立制药股份有限公司的主营业务是医药特色原料药研发、生产与销售。公司的主要产品是碘海醇注射液、碘帕醇注射液、碘克沙醇注射液、碘美普尔注射液、碘佛醇注射液、碘普罗胺注射液、钆贝葡胺注射液、钆喷酸葡胺注射液、造影剂类原料药及中间体、喹诺酮类原料药及中间体、CMO/CDMO类原料药及中间体。","listedPrice":12.15},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"司太立(603520)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供司太立(603520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"司太立,603520,司太立股票,司太立股票老虎,司太立股票老虎国际,司太立行情,司太立股票行情,司太立股价,司太立股市,司太立股票价格,司太立股票交易,司太立股票购买,司太立股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"司太立(603520)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供司太立(603520)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}